Ardent Health Partners, LLC (NYSE:ARDT) Given Average Rating of “Buy” by Brokerages

Shares of Ardent Health Partners, LLC (NYSE:ARDTGet Free Report) have been assigned an average recommendation of “Buy” from the twelve research firms that are presently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating on the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $21.82.

Several brokerages have recently commented on ARDT. Leerink Partnrs upgraded shares of Ardent Health Partners to a “strong-buy” rating in a research note on Monday, August 12th. JPMorgan Chase & Co. initiated coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set a “neutral” rating and a $18.00 price objective on the stock. Royal Bank of Canada reiterated an “outperform” rating and issued a $23.00 price objective on shares of Ardent Health Partners in a research report on Thursday, November 14th. Loop Capital started coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They set a “buy” rating and a $18.00 price objective on the stock. Finally, Leerink Partners boosted their price objective on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 12th.

View Our Latest Stock Report on ARDT

Hedge Funds Weigh In On Ardent Health Partners

Several hedge funds have recently added to or reduced their stakes in ARDT. Seven Grand Managers LLC bought a new position in Ardent Health Partners during the 3rd quarter worth approximately $2,298,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of Ardent Health Partners during the third quarter worth about $13,119,000. Financial Management Professionals Inc. acquired a new stake in shares of Ardent Health Partners during the third quarter worth about $50,000. Charles Schwab Investment Management Inc. acquired a new position in shares of Ardent Health Partners in the 3rd quarter valued at approximately $526,000. Finally, BNP Paribas Financial Markets bought a new stake in Ardent Health Partners during the 3rd quarter worth approximately $42,000.

Ardent Health Partners Stock Performance

Ardent Health Partners stock opened at $16.17 on Wednesday. The stock’s 50 day moving average is $17.97. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. Ardent Health Partners has a one year low of $14.57 and a one year high of $20.72.

Ardent Health Partners Company Profile

(Get Free Report

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

See Also

Analyst Recommendations for Ardent Health Partners (NYSE:ARDT)

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.